SEUM Represents Daewoong Pharmaceutical in Establishment of Joint Venture with NAVER
SEUM advised Daewoong Pharmaceutical Co., Ltd., a Korean pharmaceutical company in its establishment of a joint venture company with Korea’s leading internet portal company Naver Corporation. The joint venture company will engage in R&D for healthcare data, utilizing AI technology.
Naver is a publicly-listed internet company that provides various online services including e-commerce, video streaming platforms, social media, language translation, web browsing and navigation. With respect to the joint venture, Naver’s COO Choi In-hyeok was quoted as saying the joint venture company’s “artificial intelligence and other IT technologies will create innovation in the healthcare field.”
The SEUM team was comprised of corporate partners Hoseok Jung and Seungkyu Byun.
Please note that the article is only available in Korean.